China Universal Asset Management Co., Ltd. Enanta Pharmaceuticals Inc Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q2 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 4,293 shares of ENTA stock, worth $44,346. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,293
Previous 4,279
0.33%
Holding current value
$44,346
Previous $23,000
39.13%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ENTA
# of Institutions
107Shares Held
18.8MCall Options Held
50KPut Options Held
0-
Farallon Capital Management LLC San Francisco, CA2.12MShares$21.9 Million0.07% of portfolio
-
Krensavage Asset Management, LLC New York, NY2.11MShares$21.8 Million8.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$20.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$19.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.46MShares$15.1 Million0.01% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $214M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...